Glycopyrrolate Injection, Solution
Product Images NDC 71872-7196

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71872-7196). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

71872-7196-1.pdp (71872 7196 1)

71872-7196-1.pdp (71872 7196 1)
Glycopyrrolate Injection, USP is available in a 5mL multiple dose vial containing 1mg/5 mL (0.2 mg/mL) of the drug. The injection can be administered either through intravenous or intramuscular route, and should not be used for newborns. The injection contains Benzyl Alcohol as a preservative and is mixed with water for Injection USP. It has to be stored between 20°C and 25°C (68°and77°F), and its usual dosage can be checked using the package insert. The lot number of the vial is available in the text, and it has been manufactured by Piramal Critical Care, based in Bethlehem, USA. The product has been repackaged by Medical Purchasing Solutions, based in Scottsdale, USA, and it is made in India.*
FDA Label Image

Glyco 5 mL Label (Glyco 5 mL Label)

Glyco 5 mL Label (Glyco 5 mL Label)
FDA Label Image
Glycopyrrolate Injection Usp, 0.2 mg/ mL (logo)
FDA Label Image

Glycopyrrolate Structure (Glycopyrrolate Str)

Glycopyrrolate Structure (Glycopyrrolate Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.